Gene · 839
Papers3,659
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 3,659
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lotus (Nelumbo nucifera Gaertn.) and Its Bioactive Phytocompounds: A Tribute to Cancer Prevention and Intervention. | Cancers (Basel) | 2022 | 35158798 | PubTator, text mining | PubMed |
| Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma. | J Clin Lab Anal | 2022 | 35156730 | PubTator, text mining | PubMed |
| Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. | Front Immunol | 2022 | 35154117 | PubTator, text mining | PubMed |
| FGF4 protects the liver from nonalcoholic fatty liver disease by activating the AMP-activated protein kinase-Caspase 6 signal axis. | Hepatology | 2022 | 35152446 | PubTator, text mining | PubMed |
| A novel defined risk signature based on pyroptosis-related genes can predict the prognosis of prostate cancer. | BMC Med Genomics | 2022 | 35135561 | PubTator, text mining | PubMed |
| The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma. | Cancer Cell Int | 2022 | 35135529 | PubTator, text mining | PubMed |
| Development of a prognostic pyroptosis-related gene signature for head and neck squamous cell carcinoma patient. | Cancer Cell Int | 2022 | 35123464 | PubTator, text mining | PubMed |
| The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma. | Mol Med | 2022 | 35123387 | PubTator, text mining | PubMed |
| Acetylshikonin induces autophagy-dependent apoptosis through the key LKB1-AMPK and PI3K/Akt-regulated mTOR signalling pathways in HL-60 cells. | J Cell Mol Med | 2022 | 35106915 | PubTator, text mining | PubMed |
| HucMSC exosomes promoted imatinib-induced apoptosis in K562-R cells via a miR-145a-5p/USP6/GLS1 axis. | Cell Death Dis | 2022 | 35091542 | PubTator, text mining | PubMed |
| Advances in Understanding the Role of Aloe Emodin and Targeted Drug Delivery Systems in Cancer. | Oxid Med Cell Longev | 2022 | 35087619 | PubTator, text mining | PubMed |
| Pyroptosis in glioblastoma: A crucial regulator of the tumour immune microenvironment and a predictor of prognosis. | J Cell Mol Med | 2022 | 35083859 | PubTator, text mining | PubMed |
| Selective elimination of pluripotent stem cells by PIKfyve specific inhibitors. | Stem Cell Reports | 2022 | 35063131 | PubTator, text mining | PubMed |
| Novel Risk Classification Based on Pyroptosis-Related Genes Defines Immune Microenvironment and Pharmaceutical Landscape for Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 35053610 | PubTator, text mining | PubMed |
| Cytoplasmic RNA sensors and their interplay with RNA-binding partners in innate antiviral response: theme and variations. | RNA | 2022 | 35031583 | PubTator, text mining | PubMed |
| Antineoplastic effects of erufosine on small cell and non-small cell lung cancer cells through induction of apoptosis and cell cycle arrest. | Mol Biol Rep | 2022 | 35015224 | PubTator, text mining | PubMed |
| Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis. | Sci Rep | 2022 | 35013445 | PubTator, text mining | PubMed |
| Nuclear Cytoskeleton in Virus Infection. | Int J Mol Sci | 2022 | 35009004 | PubTator, text mining | PubMed |
| Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. | Int J Biol Sci | 2022 | 35002520 | PubTator, text mining | PubMed |
| Cannabinoid receptor type 2 agonist JWH-133 decreases cathepsin B secretion and neurotoxicity from HIV-infected macrophages. | Sci Rep | 2022 | 34996989 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/839/papers?page=38